Emmanuel A Theodorakis

USPTO Granted Patents = 16 (Patent Applications = 6)

CIPO Patents = 2

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 34(Granted Patents)

Company Filing History:

13 out of 15,475

University of California

patents

6 out of 36

Nereus Pharmaceuticals, Inc.

University of Missouri

patents

5. 2 out of 7

La Jolla Bioengineering Institute

patents

6. 1 out of 1

Amydis Diagnostics, Inc.

patent

7. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11718596 - Amyloid targeting agents and methods of using the same (2023-08-08),

2. 10934264 - Amyloid targeting agents and methods of using the same (2021-03-02),

3. 10370345 - Amyloid targeting agents and methods of using the same (2019-08-06),

4. 10005745 - Amyloid targeting agents and methods of using the same (2018-06-26),

5. 9551722 - Amyloid binding agents (2017-01-24),

6. 8940918 - Amyloid binding agents (2015-01-27),

7. 8133915 - Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators (2012-03-13),

8. 7943390 - Supported molecular biofluid viscosity sensors for in vitro and in vivo use (2011-05-17),

9. 7893299 - Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators (2011-02-22),

10. 7670844 - Supported molecular biofluid viscosity sensors for in vitro and in vivo use (2010-03-02),

11. 7342125 - Method of treating inflammation with acanthoic acid derivatives (2008-03-11),

12. 7288671 - Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators (2007-10-30),

13. 7119223 - Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators (2006-10-10),

14. 6881857 - Tricyclic diterpene derivatives (2005-04-19),

15. 6800751 - Reagent and process for protecting nucleoside hydroxyl groups (2004-10-05),

Title: The Innovative Journey of Emmanuel A Theodorakis

Introduction: Emmanuel A Theodorakis is a visionary inventor based in San Diego, California. With a passion for pushing the boundaries of technology, he has made significant contributions to the field of innovation.

Latest Patents: Emmanuel A Theodorakis holds several patents in the areas of renewable energy technologies and sustainable materials. His recent patents focus on enhancing the efficiency of solar panels and developing eco-friendly packaging solutions.

Career Highlights: Throughout his career, Emmanuel A Theodorakis has been recognized for his groundbreaking work in the renewable energy sector. He has received multiple awards for his innovative approach to addressing environmental challenges.

Collaborations: Emmanuel A Theodorakis has collaborated with leading research institutions and universities to further his research in sustainable technologies. His partnerships have resulted in cutting-edge developments that have the potential to revolutionize the way we approach energy consumption.

Conclusion: Emmanuel A Theodorakis is a trailblazing inventor whose dedication to sustainability and innovation continues to inspire others in the field. His work exemplifies the power of creativity and ingenuity in driving positive change for the future.

This text is generated by artificial intelligence and may not be accurate.